The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial
Open accessAbstract
Importance: Vaporization is an increasingly popular method for cannabis administration, and policy changes have increased adult access to cannabis drastically. Controlled examinations of cannabis vaporization among adults with infrequent current cannabis use patterns (>30 days since last use) are needed. Objective: To evaluate the acute dose effects of smoked and vaporized cannabis using controlled administration methods. Design, Setting, and Participants: This within-participant, double-blind, crossover study was conducted from June 2016 to January 2017 at the Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine, and included 17 healthy adults. Six smoked and vaporized outpatient experimental sessions (1-week washout between sessions) were completed in clusters (order counterbalanced across participants); dose order was randomized within each cluster. Interventions: Cannabis containing Δ9-tetrahydrocannabinol (THC) doses of 0 mg, 10 mg, and 25 mg was vaporized and smoked by each participant. Main Outcomes and Measures: Change from baseline scores for subjective drug effects, cognitive and psychomotor performance, vital signs, and blood THC concentration. Results: The sample included 17 healthy adults (mean [SD] age, 27.3 [5.7] years; 9 men and 8 women) with no cannabis use in the prior month (mean [SD] days since last cannabis use, 398 [437] days). Inhalation of cannabis containing 10 mg of THC produced discriminative drug effects (mean [SD] ratings on a 100-point visual analog scale, smoked: 46 [26]; vaporized: 69 [26]) and modest impairment of cognitive functioning. The 25-mg dose produced significant drug effects (mean [SD] ratings, smoked: 66 [29]; vaporized: 78 [24]), increased incidence of adverse effects, and pronounced impairment of cognitive and psychomotor ability (eg, significant decreased task performance compared with placebo in vaporized conditions). Vaporized cannabis resulted in qualitatively stronger drug effects for most pharmacodynamic outcomes and higher peak concentrations of THC in blood, compared with equal doses of smoked cannabis (25-mg dose: smoked, 10.2 ng/mL; vaporized, 14.4 ng/mL). Blood THC concentrations and heart rate peaked within 30 minutes after cannabis administration and returned to baseline within 3 to 4 hours. Several subjective drug effects and observed cognitive and psychomotor impairments persisted for up to 6 hours on average. Conclusions and Relevance: Vaporized and smoked cannabis produced dose-orderly drug effects, which were stronger when vaporized. These data can inform regulatory and clinical decisions surrounding the use of cannabis among adults with little or no prior cannabis exposure. Trial Registration: ClinicalTrials.gov Identifier: NCT03676166.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Design and Analysis: A Researcher's Handbook
Beaton, A. E., & Keppel, G. (1975) · American Educational Research Journal · doi:10.2307/1162588 · Cited by 5,822
Sobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110
(1969) · Occupational Therapy: the Official Journal of the Association of Occupational Therapists · doi:10.1177/030802266903200417 · Cited by 982
Gmel, G., & Rehm, J. (2004) · Contemporary Drug Problems · doi:10.1177/009145090403100304 · Cited by 466
Compton, W. M., Han, B., Jones, C. M., Blanco, C., & Hughes, A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30208-5 · Cited by 377
An automated version of the digit symbol substitution test (DSST)
McLeod, D. R., Griffiths, R. R., Bigelow, G. E., & Yingling, J. (1982) · Behavior Research Methods & Instrumentation · doi:10.3758/bf03203313 · Cited by 365
Self-citationBerg, C. J., Stratton, E., Schauer, G. L., Lewis, M., Wang, Y., Windle, M., & Kegler, M. (2015) · Substance Use & Misuse · doi:10.3109/10826084.2014.958857 · Cited by 338
Russell, C., Rueda, S., Room, R., Tyndall, M., & Fischer, B. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.11.008 · Cited by 298
High School Students’ Use of Electronic Cigarettes to Vaporize Cannabis
Morean, M. E., Kong, G., Camenga, D. R., Cavallo, D. A., & Krishnan-Sarin, S. (2015) · Pediatrics · doi:10.1542/peds.2015-1727 · Cited by 263
Vaporization as a Smokeless Cannabis Delivery System: A Pilot Study
Abrams, D. I., Vizoso, H. P., Shade, S. B., Jay, C., Kelly, M. E., & Benowitz, N. L. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100200 · Cited by 243
Vandrey, R., Herrmann, E. S., Mitchell, J. M., Bigelow, G. E., Flegel, R., LoDico, C., & Cone, E. J. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx012 · Cited by 215
Self-citationVaping cannabis (marijuana): parallel concerns to e‐cigs?
Budney, A. J., Sargent, J. D., & Lee, D. C. (2015) · Addiction · doi:10.1111/add.13036 · Cited by 200
Newmeyer, M. N., Swortwood, M. J., Barnes, A. J., Abulseoud, O. A., Scheidweiler, K. B., & Huestis, M. A. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.263475 · Cited by 181
Online survey characterizing vaporizer use among cannabis users
Lee, D. C., Crosier, B. S., Borodovsky, J. T., Sargent, J. D., & Budney, A. J. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.12.020 · Cited by 146
Gieringer, D. H., Laurent, J. S., & Goodrich, S. (2004) · Journal of Cannabis Therapeutics · doi:10.1300/j175v04n01_02 · Cited by 121
Cone, E. J., & Huestis, M. A. (1993) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199312000-00013 · Cited by 99
Self-citationNewmeyer, M. N., Swortwood, M. J., Abulseoud, O. A., & Huestis, M. A. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.02.003 · Cited by 92
Cannabis smoke condensate III: The cannabinoid content of vaporised Cannabis sativa
Pomahačová, B., van der Kooy, F., & Verpoorte, R. (2009) · Inhalation Toxicology · doi:10.3109/08958370902748559 · Cited by 90
Herrmann, E. S., Cone, E. J., Mitchell, J. M., Bigelow, G. E., LoDico, C., Flegel, R. R., & Vandrey, R. G. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.03.019 · Cited by 83
Self-citationHooker, W. D., & Jones, R. T. (1987) · Psychopharmacology · doi:10.1007/bf00690920 · Cited by 82
Electronic Cigarettes and Cannabis: An Exploratory Study
Etter, J. (2015) · European Addiction Research · doi:10.1159/000369791 · Cited by 70
The Form and Content of Cannabis Products in the United States
Steigerwald, S., Wong, P. O., Khorasani, A., & Keyhani, S. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4480-0 · Cited by 66
Effects of marijuana on performance of a computerized cognitive-neuromotor test battery
Wilson, W. H., Ellinwood, E. H., Mathew, R. J., & Johnson, K. S. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90031-0 · Cited by 62
Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers.
Kleykamp, B. A., Griffiths, R. R., & Mintzer, M. Z. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0018407 · Cited by 48
Barrett, F. S., Schlienz, N. J., Lembeck, N. A., Waqas, M., & Vandrey, R. G. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0052 · Cited by 41
Self-citationCoulter, C., Miller, E., Crompton, K., & Moore, C. M. (2008) · Journal of Analytical Toxicology · doi:10.1093/jat/32.8.653 · Cited by 37
The effect of interactions between genetics and cannabis use on neurocognition. A review
Cosker, E., Schwitzer, T., Ramoz, N., Ligier, F., Lalanne, L., Gorwood, P. A. P. M., Schwan, R., & Laprévote, V. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.024 · Cited by 30
Toward a Regulatory Framework for the Legalization of Cannabis: How Do We Get to There from Here?
Cyrenne, P., & Shanahan, M. (2018) · Canadian Public Policy · doi:10.3138/cpp.2017-026 · Cited by 15
Cited by
Fischer, B., Robinson, T., Bullen, C., Curran, V., Jutras-Aswad, D., Medina-Mora, M. E., Pacula, R. L., Rehm, J., Room, R., Brink, W. V. D., et al. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103381 · Cited by 236
McCartney, D., Arkell, T. R., Irwin, C., & McGregor, I. S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.003 · Cited by 170
Rasera, G. B., Ohara, A., & de Castro, R. J. S. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.06.035 · Cited by 44
Effects of different methods of cannabis use on cognition and blood THC: A systematic review.
Behzad, D., Patel, S., Besa, R., Chan, A. W. H., Chen, S., Rueda, S., Ruocco, A. C., & Di Ciano, P. (2025) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111399 · Cited by 7
Metadata
- Authors
- Spindle, T. R., Cone, E. J., Schlienz, N. J., Mitchell, J. M., Bigelow, G. E., Flegel, R., Hayes, E., & Vandrey, R.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2018-11-30
- Volume
- 1
- Issue
- 7
- Pages
- e184841
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W2902194821
- Cited by
- 265
- References
- 29
- FWCI
- 13.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.